SCI Cancer Clinical Trials Office Blog

News & Updates from the SCI-CCTO
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
  • Cancer Clinical Trials Office
  • Stanford Cancer Institute

SRC Reminder – New Version of the Protocol Statement of Support

March 8, 2022 - SCI Communications

The initial Protocol Statement of Support (PSOS) has been updated (version 4- dated 8 Dec 2021). 

And is now available on the Scientific Review Committee (SRC) website to download. 

https://med.stanford.edu/cancer/research/trial-support/src/research-groups.html

Key update: An additional question regarding interim efficacy or safety analysis was added to the “scientific importance of the study” section.   

Scientific Importance of Study

D. Is an interim efficacy or safety analysis included in the study design of this protocol: 

  • Yes   
  • No 

If not Included, provide the justification of not including it in the study design. 

For industry sponsored trials, the justification of not including efficacy or safety analysis in study design should be discussed with the sponsor.

In case of any questions, please reach out to the SRC office at src-office@stanford.edu

Kindly make sure you are using this revised version going forward. CCTO intake will reject all the old versions of PSOS if they have a CRG meeting date of February 15 or later.

Blog Submissions

If you have an announcement for the blog, please complete the Comms Request Form.

Reminder: Please have your blog post submitted to us by noon on Wednesday in order to have your post featured in the weekly email digest on Friday morning.

Archives

Categories

  • Announcements
  • Clinical Trials
  • Coordinator Corner
  • Educational Training
  • Events
  • Intake Process
  • IRB Updates
  • kudos
  • OnCore
  • Quality Corner
  • Regulatory Updates
  • Remote Monitoring
  • SCI Messages
  • Scientific Review Committee (SRC)
  • SOP/Guideline Updates
  • Staff Updates
  • Uncategorized
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube